New drug shows promise for slowing kidney decline in alport syndrome
Disease control
Completed
This study tested a drug called vonafexor in 26 people with Alport syndrome, a genetic condition that damages kidneys. The goal was to see if the drug is safe and can help slow down kidney function loss. Participants took different doses of the drug, and researchers measured side…
Phase: PHASE2 • Sponsor: Enyo Pharma • Aim: Disease control
Last updated May 17, 2026 13:22 UTC